Log in
Enquire now
‌

US Patent 10273227 C5-anilinoquinazoline compounds and their use in treating cancer

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102732270
Patent Inventor Names
Jason Kettle0
James Smith0
Stuart Pearson0
Martin Packer0
Date of Patent
April 30, 2019
0
Patent Application Number
159631220
Date Filed
April 26, 2018
0
Patent Citations Received
‌
US Patent 11858995 Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia
0
‌
US Patent 11535679 Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
‌
US Patent 11548952 Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma
‌
US Patent 10829479 C
‌
US Patent 11608383 Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
0
Patent Primary Examiner
‌
Matthew P Coughlin
0
Patent abstract

The invention concerns compounds of Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10273227 C5-anilinoquinazoline compounds and their use in treating cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.